April 1, 2024

ProChem, Inc.

ProChem Inc. Announces Expansion with New Facility Addition

Rockford, ILProChem Inc. is pleased to announce the expansion of its facility with the addition of a new building on their existing site. This expansion is a continuation of their 5-year business plan to increase manufacturing space and capabilities. This will also meet the more recent market need to onshore critical raw materials driven by computer chip fabrication expansions in the US and CHIPS Act funding.

The additional space gives ProChem increased capability to offer flexible manufacturing and locations for additional capital investments to increase overall manufacturing capacity. ProChem’s recent renovations reflect their dedication to staying at the forefront of the industry.

How the Expansion Journey Began

In 2021, a 5-year expansion plan was launched with a focus on the future of advanced materials and creating a robust US based manufacturing source. In the course of 2022, they expanded their activities into diverse high-tech areas by supplying ‘Precursors for Precursors’ to the companies and researchers operating in such technology sectors as catalysis, thin film deposition, crystal growth, and energy generation and storage.

In 2023, ProChem completed their new R&D Laboratory as well as a renovation of their Analytical Laboratory with the addition of state-of-the-art instrumentation. By doing this, it has streamlined the production process and decreased lead times for their products.

As ProChem’s Founder and CEO, Reno Novak recently stated, “A lot of innovative products are sitting in college or university’s labs – we plan to identify those with commercial application and get them out of the shadows and into production.”

About ProChem
ProChem Inc. was founded in 1986 by Reno Novak and has been supplying a variety of industries with unique rare earth, inorganic, and metal organic compounds for over 35 years. These products are utilized in a wide range of applications including computer chip technology, lasers, ceramics, alternative energy, and biomedical technologies. ProChem Inc. has also been involved in several groundbreaking projects such as producing the highest purity Potassium Dihydrogen Phosphate for growing extremely large crystals used at the National Ignition Facility (NIF), and the production of a catalyst for the emergency mass production of Remdesivir, an FDA approved medication for the treatment of hospitalized COVID-19 patients.

ProChem Inc. is committed to providing its customers with high quality products and innovative solutions for their advanced materials applications. The company offers dedicated equipment for custom manufacturing of exclusive materials, product specific packaging, purification services, as well as custom blending and tolling. ProChem Inc. also has an analytical laboratory equipped with various instruments to ensure the compliance of its products with both standard catalog and unique custom specifications. View ProChem’s products online at and contact for custom product quotations.

Categorized in: